A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Germany

University Children's Hospital Heidelberg, Cystic Fibrosis Centre, Heidelberg, Baden-Wurttemberg

Universitätsmedizin Essen, Ruhrlandklinik, Essen, North Rhine-Westphalia

Charité - Universitätsmedizin Berlin, Berlin, State of Berlin